Rie Mineta

591 total citations
17 papers, 428 citations indexed

About

Rie Mineta is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Rie Mineta has authored 17 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 17 papers in Hepatology and 3 papers in Infectious Diseases. Recurrent topics in Rie Mineta's work include Hepatitis C virus research (17 papers), Hepatitis B Virus Studies (15 papers) and Liver Disease Diagnosis and Treatment (11 papers). Rie Mineta is often cited by papers focused on Hepatitis C virus research (17 papers), Hepatitis B Virus Studies (15 papers) and Liver Disease Diagnosis and Treatment (11 papers). Rie Mineta collaborates with scholars based in Japan. Rie Mineta's co-authors include Norio Akuta, Fumitaka Suzuki, Tetsuya Hosaka, Yoshiyuki Suzuki, Hitomi Sezaki, Hiromitsu Kumada, Mariko Kobayashi, Yasuji Arase, Masahiro Kobayashi and Yusuke Kawamura and has published in prestigious journals such as Journal of Hepatology, Journal of Medical Virology and Scandinavian Journal of Gastroenterology.

In The Last Decade

Rie Mineta

16 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rie Mineta Japan 11 403 381 96 21 19 17 428
Peter Varunok United States 4 537 1.3× 484 1.3× 149 1.6× 17 0.8× 37 1.9× 4 557
Josep M. Guardiola Spain 11 324 0.8× 273 0.7× 184 1.9× 20 1.0× 17 0.9× 25 423
E.J. Lawitz United States 12 393 1.0× 371 1.0× 93 1.0× 15 0.7× 37 1.9× 27 409
J. McHutchison United States 11 315 0.8× 290 0.8× 81 0.8× 19 0.9× 31 1.6× 42 341
D. Perner Germany 9 355 0.9× 315 0.8× 108 1.1× 39 1.9× 27 1.4× 22 390
Rob Elston United States 5 292 0.7× 263 0.7× 103 1.1× 23 1.1× 33 1.7× 7 323
Bernd Moeller Germany 7 284 0.7× 249 0.7× 66 0.7× 15 0.7× 36 1.9× 33 341
J. Albrecht United States 10 391 1.0× 368 1.0× 64 0.7× 33 1.6× 54 2.8× 18 449
Marie Matsuda Japan 15 808 2.0× 776 2.0× 108 1.1× 19 0.9× 56 2.9× 28 836
Linda Baher United States 3 277 0.7× 248 0.7× 81 0.8× 21 1.0× 32 1.7× 3 288

Countries citing papers authored by Rie Mineta

Since Specialization
Citations

This map shows the geographic impact of Rie Mineta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rie Mineta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rie Mineta more than expected).

Fields of papers citing papers by Rie Mineta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rie Mineta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rie Mineta. The network helps show where Rie Mineta may publish in the future.

Co-authorship network of co-authors of Rie Mineta

This figure shows the co-authorship network connecting the top 25 collaborators of Rie Mineta. A scholar is included among the top collaborators of Rie Mineta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rie Mineta. Rie Mineta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Suzuki, Fumitaka, Tetsuya Hosaka, Yoshiyuki Suzuki, et al.. (2018). Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naïve chronic hepatitis B patients in Japan. Journal of Gastroenterology. 54(2). 182–193. 31 indexed citations
3.
Suzuki, Fumitaka, Yoshiyuki Suzuki, Tetsuya Hosaka, et al.. (2016). Efficacy of long-term tenofovir-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogs. Journal of Gastroenterology. 52(5). 641–651. 12 indexed citations
4.
Suzuki, Fumitaka, Hitomi Sezaki, Norio Akuta, et al.. (2014). Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir. Drug Design Development and Therapy. 8. 869–869. 5 indexed citations
5.
Suzuki, Fumitaka, Tetsuya Hosaka, Yoshiyuki Suzuki, et al.. (2013). Long-term efficacy and emergence of multidrug resistance in patients with lamivudine-refractory chronic hepatitis B treated by combination therapy with adefovir plus lamivudine. Journal of Gastroenterology. 49(6). 1094–1104. 6 indexed citations
6.
Hara, Tomohiko, Fumitaka Suzuki, Yusuke Kawamura, et al.. (2013). Long‐term entecavir therapy results in falls in serum hepatitis B surface antigen levels and seroclearance in nucleos(t)ide‐naïve chronic hepatitis B patients. Journal of Viral Hepatitis. 21(11). 802–808. 21 indexed citations
7.
Suzuki, Fumitaka, Hitomi Sezaki, Norio Akuta, et al.. (2012). Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b. Journal of Clinical Virology. 54(4). 352–354. 89 indexed citations
8.
Ono, Atsushi, Fumitaka Suzuki, Yusuke Kawamura, et al.. (2012). Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients. Journal of Hepatology. 57(3). 508–514. 126 indexed citations
9.
Suzuki, Fumitaka, Yoshiyuki Suzuki, Hitomi Sezaki, et al.. (2012). Exploratory study on telaprevir given every 8 h at 500 mg or 750 mg with peginterferon‐alpha‐2b and ribavirin in hepatitisCpatients. Hepatology Research. 43(7). 691–701. 18 indexed citations
10.
Suzuki, Fumitaka, Norio Akuta, Yoshiyuki Suzuki, et al.. (2010). Relationship between SNPs in the IL28B region and amino acid substitutions in HCV core region in Japanese patients with chronic hepatitis C. Kanzo. 51(6). 322–323. 3 indexed citations
11.
Kobayashi, Mariko, Fumitaka Suzuki, Norio Akuta, et al.. (2009). Development of hepatocellular carcinoma in elderly patients with chronic hepatitis C with or without elevated aspartate and alanine aminotransferase levels. Scandinavian Journal of Gastroenterology. 44(8). 975–983. 5 indexed citations
12.
Kobayashi, Mariko, Fumitaka Suzuki, Norio Akuta, et al.. (2009). Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment. Hepatology Research. 40(2). 125–134. 13 indexed citations
13.
Kobayashi, Mariko, Norio Akuta, Fumitaka Suzuki, et al.. (2009). Influence of amino‐acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1b. Journal of Medical Virology. 82(1). 41–48. 21 indexed citations
14.
Suzuki, Fumitaka, Yoshiyuki Suzuki, Norio Akuta, et al.. (2009). Sustained virological response in a patient with chronic hepatitis C treated by monotherapy with the NS3-4A protease inhibitor telaprevir. Journal of Clinical Virology. 47(1). 76–78. 19 indexed citations
15.
Suzuki, Fumitaka, Norio Akuta, Yoshiyuki Suzuki, et al.. (2009). Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP‐424), pegylated interferon and ribavirin for 12 weeks. Hepatology Research. 39(11). 1056–1063. 21 indexed citations
16.
Kobayashi, Mariko, Kenji Ikeda, Yasuji Arase, et al.. (2008). Change of hepatitis B virus genotypes in acute and chronic infections in Japan. Journal of Medical Virology. 80(11). 1880–1884. 33 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Varunok Breakdown of academic impact, for papers by Josep M. Guardiola Breakdown of academic impact, for papers by E.J. Lawitz Breakdown of academic impact, for papers by J. McHutchison Breakdown of academic impact, for papers by D. Perner Breakdown of academic impact, for papers by Rob Elston Breakdown of academic impact, for papers by Bernd Moeller Breakdown of academic impact, for papers by J. Albrecht Breakdown of academic impact, for papers by Marie Matsuda Breakdown of academic impact, for papers by Linda Baher
Rankless by CCL
2026